Pazopanib (P) or placebo in completely resected stage I NSCLC patients: Survival results of the phase II trial IFCT-0703.

被引：0
|
作者：
Besse, Benjamin
Mazieres, Julien
Ribassin-Majed, Laureen
Barlesi, Fabrice
Bennouna, Jaafar
Gervais, Radj
Moreau, Lionel
Berard, Henri
Debieuvre, Didier
Molinier, Oliver
Moro-Sibilot, Denis
Souquet, Pierre Jean
Pignon, Jean-Pierre
Amour, Elodie
Celebic, Aljosa
Morin, Franck
Milleron, Bernard
Zalcman, Gerard
Soria, Jean-Charles
机构：
[1] Gustave Roussy, Villejuif, France
[2] CHU Toulouse, Hop Larrey, Toulouse, France
[3] Aix Marseille Univ, Assistance Publ Hop Marseille, Marseille, France
[4] Inst Cancerol Ouest, Nantes, France
[5] Inst Baclesse, Caen, France
[6] Ctr Hosp Pneumol Colmar, Colmar, France
[7] Hop Instruct Armes St Anne, Toulon, France
[8] Emile Muller Hosp, Mulhouse, France
[9] Le Mans Reg Hosp, Le Mans, France
[10] Grenoble Univ Hosp, Grenoble, France
[11] Lyon Sud Hosp, Acute Resp Med & Thorac Oncol Dept, Pierre Benite, France
[12] Lyon Univ, Inst Canc, Lyon Univ Hosp, Pierre Benite, France
[13] IFCT, Paris, France
[14] Inst Gustave Roussy, Villejuif, France
[15] Intergrp Francophone Cancerol Thorac, Paris, France
[16] Caen Univ Hosp, Caen, France
[17] Gustave Roussy Canc Campus, Drug Dev Dept, Villejuif, France
来源：
JOURNAL OF CLINICAL ONCOLOGY | 2015年 / 33卷 / 15期
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
7510
引用
收藏
页数：1
相关论文
共 50 条
  • [31] Phase I clinical trial of a novel autologous modified-DC vaccine in patients with resected NSCLC
    Chunlei Ge
    Ruilei Li
    Haifeng Song
    Tao Geng
    Jinyan Yang
    Qinghua Tan
    Linfeng Song
    Ying Wang
    Yuanbo Xue
    Zhen Li
    Suwei Dong
    Zhiwei Zhang
    Na Zhang
    Jiyin Guo
    Lin Hua
    Siyi Chen
    Xin Song
    BMC Cancer, 17
  • [32] Phase I clinical trial of a novel autologous modified-DC vaccine in patients with resected NSCLC
    Ge, Chunlei
    Li, Ruilei
    Song, Haifeng
    Geng, Tao
    Yang, Jinyan
    Tan, Qinghua
    Song, Linfeng
    Wang, Ying
    Xue, Yuanbo
    Li, Zhen
    Dong, Suwei
    Zhang, Zhiwei
    Zhang, Na
    Guo, Jiyin
    Hua, Lin
    Chen, Siyi
    Song, Xin
    BMC CANCER, 2017, 17
  • [33] Telomerase Peptide Vaccination in NSCLC: A Phase II Trial in Stage III Patients Vaccinated after Chemoradiotherapy and an 8-Year Update on a Phase I/II Trial
    Brunsvig, Paal Fr.
    Kyte, Jon Amund
    Kersten, Christian
    Sundstrum, Stein
    Muller, Mona
    Nyakas, Marta
    Hansen, Gaute L.
    Gaudernack, Gustav
    Aamdal, Steinar
    CLINICAL CANCER RESEARCH, 2011, 17 (21) : 6847 - 6857
  • [34] SBRT with concurrent chemoradiation in stage III NSCLC: first results of the phase I Hybrid trial
    Peulen, H.
    Sonke, J. J.
    Van der Bijl, E.
    Damen, E.
    Belderbos, J.
    RADIOTHERAPY AND ONCOLOGY, 2016, 119 : S129 - S129
  • [35] Results of the TAPPAS trial: An adaptive enrichment phase III trial of TRC105 and pazopanib (P) versus pazopanib alone in patients with advanced angiosarcoma (AS)
    Jones, R. L.
    Ravi, V.
    Brohl, A. S.
    Chawla, S. P.
    Ganjoo, K.
    Italiano, A.
    Attia, S.
    Burgess, M.
    Thornton, K.
    Cranmer, L.
    Liu, L.
    Theuer, C.
    Maki, R.
    ANNALS OF ONCOLOGY, 2019, 30 : 683 - 683
  • [36] Proteomic screening of completely resected tumors in relation to survival in patients with stage I non-small cell lung cancer
    Oshita, Fumihiro
    Morita, Atsushi
    Ito, Hiroyuki
    Kameda, Yoichi
    Tsuchiya, Eiju
    Asai, Shigeru
    Miyagi, Yohei
    ONCOLOGY REPORTS, 2010, 24 (03) : 637 - 645
  • [37] Initial results of the phase ib/II, I-START trial: Isotoxic accelerated radiotherapy for the treatment of stage II-IIIb NSCLC.
    Lester, Jason Francis
    Courtier, Nicholas
    Eswar, Chinnamani
    Mohammed, Nazia
    Fenwick, John
    Griffiths, Gareth
    Nixon, Lisette Sheena
    JOURNAL OF CLINICAL ONCOLOGY, 2018, 36 (15)
  • [38] Long-term results of a prospective phase II trial of medically inoperable stage I NSCLC treated with SBRT - the Nordic experience
    Lindberg, Karin
    Nyman, Jan
    Kallskog, Vendela Riesenfeld
    Hoyer, Morten
    Lund, Jo A.
    Lax, Ingmar
    Wersall, Peter
    Karlsson, Kristin
    Friesland, Signe
    Lewensohn, Rolf
    ACTA ONCOLOGICA, 2015, 54 (08) : 1096 - 1104
  • [39] ZD6474 plus docetaxel in patients with previously treated NSCLC: Results of a randomized, placebo-controlled Phase II trial
    Herbst, R
    Johnson, B
    Rowbottom, J
    Fidias, P
    Lu, C
    Prager, D
    Roubec, J
    Csada, E
    Dimery, I
    Heymach, J
    LUNG CANCER, 2005, 49 : S35 - S36
  • [40] A phase I/II trial of pazopanib alternating with bevacizumab in treatment-naive metastatic clear cell renal cell carcinoma (CCRCC) patients: Phase I results.
    George, Saby
    Herbst, Laurie
    Sikorski, Marcus
    Diraddo, Ann Marie
    Azabdaftari, Gissou
    Roche, Charles
    Kauffman, Eric
    Li, Qiang
    Schwaab, Thomas
    Levine, Ellis Glenn
    Pili, Roberto
    Chatta, Gurkamal S.
    Appleman, Leonard Joseph
    Groman, Adrienne
    Parikh, Rahul Atul
    Hutson, Alan
    JOURNAL OF CLINICAL ONCOLOGY, 2019, 37 (07)
12345